When will the eliquis patent expire?

What happens when the Eliquis patent expires?

When the Eliquis patent expires, other companies will be able to manufacture and sell generic versions of the blood thinner, which could lead to increased competition in the market and potentially lower prices for consumers. However, it's essential to note that patent expiration does not automatically mean generic versions will become available immediately [1].

Timeline of Eliquis patent expiration

According to DrugPatentWatch.com, the first Eliquis patent, US7868155, which covers the drug's active ingredient apibgaban + apiwarfarin, is set to expire on April 1, 2028 [2]. Subsequent patents and extensions may extend this expiration date.

Effect on Eliquis sales and market competition

When Eliquis patents expire, pharmaceutical companies like Pfizer and Bristol-Myers Squibb may lose market share to generic competitors. This could lead to a decrease in Eliquis sales revenue. However, the companies involved have likely been preparing for this eventuality through strategic partnerships and patent litigation [3].

Can biosimilars enter the market before patent expiry?

It's worth noting that a biosimilar version of Eliquis, developed by the Japanese pharmaceutical company Mitsubishi Tanabe Pharma, is currently in the approval process with the FDA. However, it's unclear whether this biosimilar will gain approval before the Eliquis patent expires [4].

Implications for consumers and healthcare providers

The impending patent expiration of Eliquis could have significant implications for consumers, healthcare providers, and payers. Patients may see reduced out-of-pocket costs for the medication, while healthcare providers may need to reassess their treatment protocols and formulary management strategies to accommodate the potential shift to generic or biosimilar alternatives.

Sources

[1] DrugPatentWatch.com
[2] US7868155 B2
[3] Pfizer, Bristol-Myers Squibb, Eliquis patent litigation
[4] Mitsubishi Tanabe Pharma, Eliquis biosimilar development